ANA Therapeutics Announces U.S. FDA Clearance Of IND Application To Initiate Clinical Trial Of Niclosamide In COVID-19 Patients

/PRNewswire/ — ANA Therapeutics (ANA), a Silicon Valley-based biotech
start-up announced today that the U.S. Food and Drug Administration (FDA)
has cleared…

No Comments

Sorry, the comment form is closed at this time.